查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1122568

乳房重建的全球市場預測(2022年～2027年)

Breast Reconstruction Market - Forecasts from 2022 to 2027
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球乳房重建的市場規模預測將從2020年的11億4,915萬美元以年複合成長率7.52％增長，達到2027年末為19億914萬7,000美元。

隨著全球乳腺癌發病率的上升，預計市場將在預測期內顯示出強勁的增長前景。乳房切除術後對乳房重建的需求不斷增加，也使預測期內的市場增長。

目錄

第1章 簡介

  • 市場概要
  • COVID-19影響
  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 在產業的競爭企業間的敵對關係
  • 產業價值鏈分析

第5章 乳房重建市場分析:各類型

  • 簡介
  • 植入
    • 矽植入
    • 生理食鹽水植入
  • 組織擴張

第6章 乳房重建市場分析:乳房切除

  • 簡介
  • 單邊
  • 雙方

第7章 乳房重建市場分析:各終端用戶

  • 簡介
  • 醫院
  • 美容診所
  • 門診病人手術中心

第8章 乳房重建市場分析:各地區

  • 簡介
  • 北美
    • 北美的乳房重建市場:各類型(2020年～2027年)
    • 北美的乳房重建市場:乳房切除(2020年～2027年)
    • 北美的乳房重建市場:各終端用戶(2020年～2027年)
    • 各國
  • 南美
    • 南美的乳房重建市場:各類型(2020年～2027年)
    • 南美的乳房重建市場:乳房切除(2020年～2027年)
    • 南美的乳房重建市場:各終端用戶(2020年～2027年)
    • 各國
  • 歐洲
    • 歐洲的乳房重建市場:各類型(2020年～2027年)
    • 歐洲的乳房重建市場:乳房切除(2020年～2027年)
    • 歐洲的乳房重建市場:各終端用戶(2020年～2027年)
    • 各國
  • 中東·非洲
    • 中東·非洲的乳房重建市場:各類型(2020年～2027年)
    • 中東·非洲的乳房重建市場:乳房切除(2020年～2027年)
    • 中東·非洲的乳房重建市場:各終端用戶(2020年～2027年)
    • 各國
  • 亞太地區
    • 亞太地區的乳房重建市場:各類型(2020年～2027年)
    • 亞太地區的乳房重建市場:乳房切除(2020年～2027年)
    • 亞太地區的乳房重建市場:各終端用戶(2020年～2027年)
    • 各國

第9章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業與市場盈利
  • 合併·收購·契約·聯盟
  • 供應商的競爭力矩陣

第10章 企業簡介

  • Johnson & Johnson Services, Inc.
  • Allergan plc
  • Ideal Implant Incorporated
  • Integra LifeSciences Corporation
  • RTI Surgical Holdings, Inc.
  • Sientra, Inc.
簡介目錄
Product Code: KSI061613790

The global breast reconstruction market is predicted to grow at a CAGR of 7.52% from a market value of US$1,149.150 million in 2020 to reach a market value of US$1,909.147 million by the end of 2027.

Breast reconstruction is referred to as a surgical procedure that involves the restoration of the shape of breasts after a mastectomy procedure. Mastectomy is required to treat or prevent a patient from breast cancer. Hence, with the growing incidences of breast cancer globally, the market is projected to show strong growth prospects during the forecast period. Also, the growing demand for immediate breast reconstruction procedures following mastectomy further allows the market to thrive in the forecast period.

Reconstruction surgery involves implants to reshape the breasts or may involve reconstruction using their body tissues. Other types of reconstruction to reshape breasts include breast reduction, breast lift, and revision of scar.

Furthermore, with technological advancements and companies offering varied products in the form of implants or mesh, the market for breast reconstruction holds favourable growth prospects during the forecast period.

Based on geography, North America and Europe are projected to hold a significant market share in the global breast reconstruction market with advanced healthcare facilities. Additionally, prominent market players offering advanced breast reconstruction products are further propelling the market growth in these regions during the forecast period. For example, Sientra, a public medical device company headquartered in Santa Barbara, CA, United States, offers breast implants with high-strength cohesive silicone gel. The FDA-approved breast implants are available to board-certified and board-eligible plastic surgeons only.

On the other hand, the Asia Pacific region is projected to grow with a high growth rate over the next five years due to increasing awareness regarding breast reconstruction procedures.

COVID-19 Impact on Breast Reconstruction Market

During COVID-19, breast reconstruction has taken a back as the healthcare sector was focused on dealing with the disease outbreak. The time demanded to deal with the coronavirus patient was given priority treatment over all the other treatments; procedures were put on hold, and burn of heat had to be borne by aesthetic surgeons. Breast reconstruction is majorly required by breast cancer patients immediately after breast cancer surgery. According to the Journal of Plastic, Reconstructive, and Aesthetic Surgery in February 2022, oncologic breast treatments and reconstructive surgeries dropped significantly by 6.8 percent and 11 percent, respectively, in 2020 compared to 2019.

The growing demand for plastic surgery among consumers will continue to increase the market demand during the forecast period.

According to a press release in September 2018 by the American Society of Plastic Surgeons (ASPS), a new survey reveals that board-certified plastic surgeons are keenly interested in adopting novel techniques, procedures, and advancements over the next ten years to keep pace with the surging consumer demands for various procedures. This is mainly because the demand for plastic surgery is soaring yearly among consumers. It was noticed that in 2017, over 17.5 million surgical and minimally invasive cosmetic procedures were done in the United States. The American Society of Plastic Surgeons, as per their survey, predicted the following emerging consumer trends regarding cosmetic and reconstructive surgery for the next ten years. Over the next ten years, it was analyzed that with solid prospects beneath the skin, cosmetic or plastic surgeons seeking advancements in skin tightening, scar management, fat grafting, and proper surgical training and certification are the top priorities.

On the other hand, it was realized that breast augmentation, tummy tucks, and liposuction are the most popular cosmetic surgical procedures. Also, regarding minimally invasive surgery, Botox is leading and is anticipated to be in high demand. This is further predicted by fillers, chemical peels, laser hair removal, dermabrasion, non-invasive fat reduction, and non-surgical skin tightening.

Furthermore, according to the March 2017press release by the ASPS, it was estimated by the American Cancer Society that in 2017, around 252,710 new cases of invasive breast cancer were projected to be diagnosed in the United States. In the previous year, breast reconstruction accounted for more than 100,000 surgeries. Steady growth was observed annually, accounting for over 30% of breast construction procedural volumes since 2000. In addition, around a 3% increase has been noticed since 2015. Besides, a parallel rise in patient-driven requests was also observed by the plastic surgeons for bilateral mastectomy along with immediate breast reconstruction. Hence, this indicates that with ongoing cancer treatments that include mastectomy, the market's strong growth potential increases during the forecast period. At present, there are over 3 million cancer survivors in the USA. Many of them are potential candidates for delayed breast reconstruction. Also, some candidates require revisions of their previous breast reconstruction, further fueling the market demand over the next five years.

Recent Development

January 2022, Mentor Worldwide LLC, the leading breast aesthetics company and a subsidiary of Johnson & Johnson Medical Devices Companies, announced that the MENTOR MemoryGel BOOSTTM Breast Implant has been authorised by the U.S. Food and Drug Administration for breast augmentation in women over the age of 22, as well as for women of all ages enduring breast reconstruction.

October 2021, Sientra, Inc., a medical aesthetics firm focused solely on plastic surgery, and Mission Plasticos, a non-profit organization committed to providing reconstructive surgical care to those in underserved populations worldwide, announced the launch of Reshaping Lives: Full Circle, a country wide program designed to offer reconstructive breast surgery to post-mastectomy women living in poverty.

May 2021, PERLE, the next generation of breast implants from GC Aesthetics, is an innovative round breast implant with Revolutionary BioQ-surface tech and highly concise Emunomic Breast Tissue Dynamic Gel that was introduced in Europe.

Segmentation:

  • By Type

Implants

  • Silicone Implants
  • Saline Implants

Tissue Expander

  • By Mastectomy

Unilateral

Bilateral

  • By End-User

Hospitals

Cosmetology Clinics

Ambulatory Surgery Centers

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • UK
  • Germany
  • France
  • Others

Middle East and Africa

  • UAE
  • Israel
  • Saudi Arabia
  • Others

Asia Pacific

  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Overview
  • 1.2. COVID-19 Impact
  • 1.3. Market Definition
  • 1.4. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Market Opportunities
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of New Entrants
    • 4.4.4. Threat of Substitutes
    • 4.4.5. Competitive Rivalry in the Industry
  • 4.5. Industry Value Chain Analysis

5. Breast Reconstruction Market Analysis, by Type

  • 5.1. Introduction
  • 5.2. Implants
    • 5.2.1. Silicone Implants
    • 5.2.2. Saline Implants
  • 5.3. Tissue Expander

6. Breast Reconstruction Market Analysis, by Mastectomy

  • 6.1. Introduction
  • 6.2. Unilateral 
  • 6.3. Bilateral

7. Breast Reconstruction Market Analysis, by End-User

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Cosmetology Clinics
  • 7.4. Ambulatory Surgery Centers

8. Breast Reconstruction Market Analysis, by Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. North America Breast Reconstruction Market, By Type, 2020 to 2027
    • 8.2.2. North America Breast Reconstruction Market, By Mastectomy, 2020 to 2027
    • 8.2.3. North America Breast Reconstruction Market, By End-User, 2020 to 2027
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. South America Breast Reconstruction Market, By Type, 2020 to 2027
    • 8.3.2. South America Breast Reconstruction Market, By Mastectomy, 2020 to 2027
    • 8.3.3. South America Breast Reconstruction Market, By End-User, 2020 to 2027
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. Europe Breast Reconstruction Market, By Type, 2020 to 2027
    • 8.4.2. Europe Breast Reconstruction Market, By Mastectomy, 2020 to 2027
    • 8.4.3. Europe Breast Reconstruction Market, By End-User, 2020 to 2027
    • 8.4.4. By Country
      • 8.4.4.1. UK
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Middle East and Africa Breast Reconstruction Market, By Type, 2020 to 2027
    • 8.5.2. Middle East and Africa Breast Reconstruction Market, By Mastectomy, 2020 to 2027
    • 8.5.3. Middle East and Africa Breast Reconstruction Market, By End-User, 2020 to 2027
    • 8.5.4. By Country
      • 8.5.4.1. United Arab Emirates
      • 8.5.4.2. Israel
      • 8.5.4.3. Saudi Arabia
      • 8.5.4.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Breast Reconstruction Market, By Type, 2020 to 2027
    • 8.6.2. Asia Pacific Breast Reconstruction Market, By Mastectomy, 2020 to 2027
    • 8.6.3. Asia Pacific Breast Reconstruction Market, By End-User, 2020 to 2027
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Thailand
      • 8.6.4.6. Indonesia
      • 8.6.4.7. Taiwan 
      • 8.6.4.8. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles 

  • 10.1. Johnson & Johnson Services, Inc.
  • 10.2. Allergan plc
  • 10.3. Ideal Implant Incorporated
  • 10.4. Integra LifeSciences Corporation
  • 10.5. RTI Surgical Holdings, Inc.
  • 10.6. Sientra, Inc.